|
Source cells (rodents) | Conditions for Exo generation | In vivo model | Dose/route of administration | Outcomes | References |
|
ESC | 40 h in culture—unclear about serum status | Mouse, MI | 10 μg total Exo protein/inj; IM inj into border zone at 2 sites | ↑ LVEF
↑ FS
↓ ESD
↓ infarct size | Khan et al. [38] |
|
BM-MSC | O/N glucose starvation, (±)IPC; serum-free, collected after 48 h | Mouse, MI | 1 μg total Exo protein; injected along border zone | ↓ infarct size with IPC | Feng et al. [51] |
10% Exo-depleted FBS, collected after 48 h; during passage 4 | Rat, MI | 20 μg total Exo protein into 2 sides along infarct border zone | ↑ LVEF
↑ FS
↓ fibrosis
↓ inflammation | Shao et al. [50] |
Overexpression of GATA4, 10% Exo-free FBS, collected after 48 h | Rat, MI | Exo from 4 × 106 cells; IM injection at border zone | ↑ LVEF
↑ FS
↓ infarct size | Yu et al. [37] |
|
Rat heart perfusate | (±)IPC | Rat, Langendorff I/R | Perfused prior to 30 min global ischemia, 2 h reperfusion | ↓ infarct size with IPC perfusate | Giricz et al. [52] |
|
CPC | 2% Exo-depleted FBS, collected after 48 h | Mouse, MI | Half of Exo collected from 5 × 105 cells; IM injection | ↓ apoptosis | Chen et al. [82] |
|
CD31+ cardiac EC | Overexpression of HIF-1α, Exo-depleted serum | Mouse, MI | 25 μg total Exo protein ± 1 × 106 CPCs; peri-infarct injection | ↑ LVEF
↑ FS
↓ Infarct size
↑ capillary density
↑ survival of transplanted CPCs | Ong et al. [36] |
|